| OAC0102 | The impact of the DREAMS package on HIV incidence among young women who sell sex in Zimbabwe: A non-randomised plausibility study | Oral abstract session with live Q&A | C8 |
| OAC0103 | Effects of economic support and community dialogue on adolescent sexual behaviour: Findings from a cluster-randomised controlled trial in Zambia | Oral abstract session with live Q&A | C43 |
| OAC0104 | What is the impact of DREAMS on HSV-2 acquisition among AGYW in rural KwaZulu-Natal, South Africa? | Oral abstract session with live Q&A | C38 |
| OAC0105 | Incorporating PrEP into standard of prevention in a clinical trial is associated with reduced HIV incidence: Evidence from the ECHO Trial | Oral abstract session with live Q&A | C36 |
| OAC0106 | Consent comprehension and waiver of caregiver consent for minors participating in sensitive research: Views of adolescent girls and caregivers in Western Kenya | Oral abstract session with live Q&A | C50 |
| OAC0202 | Outreach-based HIV testing approach from Test & Treat project in Tanzania: Mid-term results | Oral abstract session with live Q&A | C34 |
| OAC0203 | Geographic hotspots of high population HIV viremia and association with HIV incidence in a universal test-and-treat setting in rural Uganda and Kenya | Oral abstract session with live Q&A | C2 |
| OAC0204 | Impact of universal testing and treatment on sexual risk behaviour and HSV-2: Evidence from the HPTN 071 (PopART) trial in Zambia and South Africa | Oral abstract session with live Q&A | C20 |
| OAC0205 | Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men in New South Wales, Australia 2010-2018 | Oral abstract session with live Q&A | C21 |
| OAC0206 | Estimated time from HIV infection to diagnosis, 50 U.S. states and the District of Columbia, 2014'2017 | Oral abstract session with live Q&A | C19 |